173 related articles for article (PubMed ID: 26902324)
1. Clinical Trial Simulations Based on Genetic Stratification and the Natural History of a Functional Outcome Measure in Creutzfeldt-Jakob Disease.
Mead S; Burnell M; Lowe J; Thompson A; Lukic A; Porter MC; Carswell C; Kaski D; Kenny J; Mok TH; Bjurstrom N; Franko E; Gorham M; Druyeh R; Wadsworth JD; Jaunmuktane Z; Brandner S; Hyare H; Rudge P; Walker AS; Collinge J
JAMA Neurol; 2016 Apr; 73(4):447-55. PubMed ID: 26902324
[TBL] [Abstract][Full Text] [Related]
2. The Medical Research Council prion disease rating scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies.
Thompson AG; Lowe J; Fox Z; Lukic A; Porter MC; Ford L; Gorham M; Gopalakrishnan GS; Rudge P; Walker AS; Collinge J; Mead S
Brain; 2013 Apr; 136(Pt 4):1116-27. PubMed ID: 23550114
[TBL] [Abstract][Full Text] [Related]
3. Evolution of Diffusion-Weighted Magnetic Resonance Imaging Signal Abnormality in Sporadic Creutzfeldt-Jakob Disease, With Histopathological Correlation.
Eisenmenger L; Porter MC; Carswell CJ; Thompson A; Mead S; Rudge P; Collinge J; Brandner S; Jäger HR; Hyare H
JAMA Neurol; 2016 Jan; 73(1):76-84. PubMed ID: 26569479
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study.
Jones E; Hummerich H; Viré E; Uphill J; Dimitriadis A; Speedy H; Campbell T; Norsworthy P; Quinn L; Whitfield J; Linehan J; Jaunmuktane Z; Brandner S; Jat P; Nihat A; How Mok T; Ahmed P; Collins S; Stehmann C; Sarros S; Kovacs GG; Geschwind MD; Golubjatnikov A; Frontzek K; Budka H; Aguzzi A; Karamujić-Čomić H; van der Lee SJ; Ibrahim-Verbaas CA; van Duijn CM; Sikorska B; Golanska E; Liberski PP; Calero M; Calero O; Sanchez-Juan P; Salas A; Martinón-Torres F; Bouaziz-Amar E; Haïk S; Laplanche JL; Brandel JP; Amouyel P; Lambert JC; Parchi P; Bartoletti-Stella A; Capellari S; Poleggi A; Ladogana A; Pocchiari M; Aneli S; Matullo G; Knight R; Zafar S; Zerr I; Booth S; Coulthart MB; Jansen GH; Glisic K; Blevins J; Gambetti P; Safar J; Appleby B; Collinge J; Mead S
Lancet Neurol; 2020 Oct; 19(10):840-848. PubMed ID: 32949544
[TBL] [Abstract][Full Text] [Related]
5. Diagnosing Sporadic Creutzfeldt-Jakob Disease by the Detection of Abnormal Prion Protein in Patient Urine.
Luk C; Jones S; Thomas C; Fox NC; Mok TH; Mead S; Collinge J; Jackson GS
JAMA Neurol; 2016 Dec; 73(12):1454-1460. PubMed ID: 27699415
[TBL] [Abstract][Full Text] [Related]
6. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.
Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I
Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565
[TBL] [Abstract][Full Text] [Related]
7. Sporadic Creutzfeldt-Jakob disease in adults over 80 years: a 10-year review of United Kingdom surveillance.
McDermott EA; Watson N; Tam J; Centola J; Kurucu King H; Mackenzie J; Summers D; Green A; Barria MA; Smith C; Pal S
Age Ageing; 2024 May; 53(5):. PubMed ID: 38706391
[TBL] [Abstract][Full Text] [Related]
8. Clinical findings and diagnostic tests in Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease.
Krasnianski A; Meissner B; Heinemann U; Zerr I
Folia Neuropathol; 2004; 42 Suppl B():24-38. PubMed ID: 16903140
[TBL] [Abstract][Full Text] [Related]
9. Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings.
Baiardi S; Capellari S; Ladogana A; Strumia S; Santangelo M; Pocchiari M; Parchi P
J Alzheimers Dis; 2016; 50(2):465-76. PubMed ID: 26682685
[TBL] [Abstract][Full Text] [Related]
10. Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease.
Schoch G; Seeger H; Bogousslavsky J; Tolnay M; Janzer RC; Aguzzi A; Glatzel M
PLoS Med; 2006 Feb; 3(2):e14. PubMed ID: 16354106
[TBL] [Abstract][Full Text] [Related]
11. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.
Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M
J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease.
Karch A; Hermann P; Ponto C; Schmitz M; Arora A; Zafar S; Llorens F; Müller-Heine A; Zerr I
Neurobiol Aging; 2015 May; 36(5):1964-8. PubMed ID: 25749129
[TBL] [Abstract][Full Text] [Related]
13. Sporadic Creutzfeldt-Jakob Disease: A Retrospective Analysis of 104 Cases.
Qi C; Zhang JT; Zhao W; Xing XW; Yu SY
Eur Neurol; 2020; 83(1):65-72. PubMed ID: 32344417
[TBL] [Abstract][Full Text] [Related]
14. Creutzfeldt-Jakob disease surveillance in Argentina, 1997-2008.
Begué C; Martinetto H; Schultz M; Rojas E; Romero C; D'Giano C; Sevlever G; Somoza M; Taratuto AL
Neuroepidemiology; 2011; 37(3-4):193-202. PubMed ID: 22067221
[TBL] [Abstract][Full Text] [Related]
15. Validation of Revised International Creutzfeldt-Jakob Disease Surveillance Network Diagnostic Criteria for Sporadic Creutzfeldt-Jakob Disease.
Watson N; Hermann P; Ladogana A; Denouel A; Baiardi S; Colaizzo E; Giaccone G; Glatzel M; Green AJE; Haïk S; Imperiale D; MacKenzie J; Moda F; Smith C; Summers D; Tiple D; Vaianella L; Zanusso G; Pocchiari M; Zerr I; Parchi P; Brandel JP; Pal S
JAMA Netw Open; 2022 Jan; 5(1):e2146319. PubMed ID: 35099544
[TBL] [Abstract][Full Text] [Related]
16. Association of Blood and Cerebrospinal Fluid Tau Level and Other Biomarkers With Survival Time in Sporadic Creutzfeldt-Jakob Disease.
Staffaroni AM; Kramer AO; Casey M; Kang H; Rojas JC; Orrú CD; Caughey B; Allen IE; Kramer JH; Rosen HJ; Blennow K; Zetterberg H; Geschwind MD
JAMA Neurol; 2019 Aug; 76(8):969-977. PubMed ID: 31058916
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic profiles of patients with late-onset Creutzfeldt-Jakob disease differ from those of younger Creutzfeldt-Jakob patients: a historical cohort study using data from the German National Reference Center.
Karch A; Raddatz LM; Ponto C; Hermann P; Summers D; Zerr I
J Neurol; 2014 May; 261(5):877-83. PubMed ID: 24570280
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological Symptoms in Sporadic Creutzfeldt-Jakob Disease Patients in Germany.
Krasnianski A; Bohling GT; Heinemann U; Varges D; Meissner B; Schulz-Schaeffer WJ; Reif A; Zerr I
J Alzheimers Dis; 2017; 59(1):329-337. PubMed ID: 28598840
[TBL] [Abstract][Full Text] [Related]
19. Codon 129 polymorphism specific cerebrospinal fluid proteome pattern in sporadic Creutzfeldt-Jakob disease and the implication of glycolytic enzymes in prion-induced pathology.
Gawinecka J; Dieks J; Asif AR; Carimalo J; Heinemann U; Streich JH; Dihazi H; Schulz-Schaeffer W; Zerr I
J Proteome Res; 2010 Nov; 9(11):5646-57. PubMed ID: 20866111
[TBL] [Abstract][Full Text] [Related]
20. Sporadic Creutzfeldt-Jakob disease in a native Puerto Rican patient.
Del Pilar-Morales EA; Cali I; Chapas J; Bertrán-Pasarell J; Puoti G; Gambetti P; Nobo U
P R Health Sci J; 2015 Mar; 34(1):40-3. PubMed ID: 25856877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
